Articles by Centers for Disease Control and Prevention

Nirsevimab Effectively Protects Infants from RSV

The CDC data show nirsevimab is 90 percent effective in preventing infants from being hospitalized with RSV

Millions of children missed vaccinations during the COVID-19 pandemic, driving up the global number of cases

Almost 9 in 10 newborn syphilis cases in 2022 might have been prevented with timely testing and treatment during pregnancy

2023 fall–winter is the first season when vaccines for all three major respiratory viruses are available

New immunization is the first approved and recommended in the US to prevent severe RSV disease in all infants

RSV vaccination may prevent severe respiratory illnesses and hospitalization in seniors at risk

Increased investments, innovation, and focus on equity are vitally needed to end the HIV epidemic

Experts urge stakeholders to create and implement innovative prevention approaches and promising new tools

Clinical cases screened for C. auris infection spiked from 44 percent in 2019 to 95 percent in 2021

Getting vaccinated in the third trimester of pregnancy is recommended by clinicians and the CDC

As of January 11, the Ebola outbreak in Uganda has ended and entry screening to the US will be lifted

CDC will continue to monitor the situation and adjust their approach as necessary

The use of updated COVID-19 vaccines help protect against the more recent strains

Vaccinated people have substantially less risk for contracting mpox compared with those who are unvaccinated

The rapid rebound in services, if scaled up, could help reach national prevention goals